DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Visser ME. et al.
Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial.
Eur Heart J 2012;
33: 1142-1149.
We do not assume any responsibility for the contents of the web pages of other providers.